BMJ  2007;334:885 (28 April), doi:10.1136/bmj.39147.604896.55 (published 20 April 2007)

Research

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)

¹ Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ² National Heart, Lung, and Blood Institute, Bethesda, MD, ³ University of Pennsylvania School of Medicine, Philadelphia, PA, ⁴ Johns Hopkins University, Baltimore, MD, ⁵ Loyola University Health System, Maywood, IL

Objective To examine the effects of reduction in dietary sodium intake on cardiovascular events using data from two completed randomised trials, TOHP I and TOHP II.

Design Long term follow-up assessed 10-15 years after the original trial.

Setting 10 clinic sites in 1987-90 (TOHP I) and nine sites in 1990-5 (TOHP II). Central follow-up conducted by post and phone.

Participants Adults aged 30-54 years with prehypertension.

Intervention Dietary sodium reduction, including comprehensive education and counselling on reducing intake, for 18 months (TOHP I) or 36-48 months (TOHP II).

Main outcome measure Cardiovascular disease (myocardial infarction, stroke, coronary revascularisation, or cardiovascular death).

Results 744 participants in TOHP I and 2382 in TOHP II were randomised to a sodium reduction intervention or control. Net sodium reductions in the intervention groups were 44 mmol/24 h and 33 mmol/24 h, respectively. Vital status was obtained for all participants and follow-up information on morbidity was obtained from 2415 (77%), with 200 reporting a cardiovascular event. Risk of a cardiovascular event was 25% lower among those in the intervention group (relative risk 0.75, 95% confidence interval 0.57 to 0.99, P=0.04), adjusted for trial, clinic, age, race, and sex, and 30% lower after further adjustment for baseline sodium excretion and weight (0.70, 0.53 to 0.94), with similar results in each trial. In secondary analyses, 67 participants died (0.80, 0.51 to 1.26, P=0.34).

Conclusion Sodium reduction, previously shown to lower blood pressure, may also reduce long term risk of cardiovascular events.

Related Articles

In Brief
BMJ 2008 336: 12. [Extract] [Full Text] [PDF]

Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study

David Conen, Paul M Ridker, Julie E Buring, and Robert J Glynn
BMJ 2007 335: 432. [Abstract] [Full Text] [PDF]

Sodium reduction is enticing, but what is the full recipe?

Paul P Glasziou
BMJ 2007 334: 967. [Extract] [Full Text] [PDF]

Time to talk salt

Fiona Godlee
BMJ 2007 334: 0. [Extract] [Full Text]

Salty story

Douglas Kamerow
BMJ 2007 334: 0. [Extract] [Full Text]

Salt and cardiovascular disease

Francesco P Cappuccio
BMJ 2007 334: 859-860. [Extract] [Full Text] [PDF]

Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study

Hugh Tunstall-Pedoe, Mark Woodward, Roger Tavendale, Richard A' Brook, and Mary K McCluskey
BMJ 1997 315: 722-729. [Abstract] [Full Text]

This article has been cited by other articles:

• Bassuk, S. S., Manson, J. E. (2008). Lifestyle and Risk of Cardiovascular Disease and Type 2 Diabetes in Women: A Review of the Epidemiologic Evidence. AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2: 191-213 [Abstract]  
• Williams, B. (2008). The year in hypertension.. J Am Coll Cardiol 51: 1803-1817 [Full text]  
• Mimran, A., Cailar, G. d. (2008). Dietary sodium: the dark horse amongst cardiovascular and renal risk factors. Nephrol Dial Transplant 0: gfn160v1-gfn160 [Full text]  
• Covic, A., Gusbeth-Tatomir, P., Goldsmith, D. (2008). Reply. Nephrol Dial Transplant 23: 1779-1780 [Full text]  
• Shaldon, S. (2008). Negative outcome studies in end-stage renal disease: how dark are the storm clouds?. Nephrol Dial Transplant 23: 1779-1779 [Full text]  
• Shaldon, S., Vienken, J. (2008). The long forgotten salt factor and the benefits of using a 5-g-salt-restricted diet in all ESRD patients. Nephrol Dial Transplant 0: gfn175v1-gfn175 [Full text]  
• Sanders, P. W. (2008). Salt Sensitivity: It Is Not Always in the Genes. Hypertension 51: 823-824 [Full text]  
• Mann, J. F. E. (2008). What's new in hypertension 2007?. Nephrol Dial Transplant 23: 466-470 [Full text]  
• Lichtenstein, A. H., Rasmussen, H., Yu, W. W., Epstein, S. R., Russell, R. M. (2008). Modified MyPyramid for Older Adults. J. Nutr. 138: 5-11 [Abstract] [Full text]  
• Walker, J., MacKenzie, A. D., Dunning, J. (2007). Does reducing your salt intake make you live longer?. ICVTS 6: 793-798 [Abstract] [Full text]  
• Davis, A. M., Vinci, L. M., Okwuosa, T. M., Chase, A. R., Huang, E. S. (2007). Cardiovascular Health Disparities: A Systematic Review of Health Care Interventions. Med Care Res Rev 64: 29S-100S [Abstract]  
• Havas, S., Dickinson, B. D., Wilson, M. (2007). The Urgent Need to Reduce Sodium Consumption. JAMA 298: 1439-1441 [Full text]  
• Hendry, J. (2007). Reduced Salt Benefits Pre-Hypertensive Hearts. DOC News 4: 7-7 [Full text]  
• Conen, D., Ridker, P. M, Buring, J. E, Glynn, R. J (2007). Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ 335: 432-432 [Abstract] [Full text]  
• (2007). From the Library. Br. J. Ophthalmol. 91: 1098-1098 [Full text]  
• (2007). Long-Term Benefits of Dietary Sodium Reduction. Journal Watch Cardiology 2007: 2-2 [Full text]  
• Glasziou, P. P (2007). Sodium reduction is enticing, but what is the full recipe?. BMJ 334: 967-967 [Full text]  
• (2007). Long-Term Benefits of Reducing Sodium Intake. JWatch General 2007: 5-5 [Full text]  
• Cappuccio, F. P (2007). Salt and cardiovascular disease. BMJ 334: 859-860 [Full text]  

Rapid Responses:

Read all Rapid Responses

Sodium reduction, cardiovascular outcome and smoking

Trevor LP Watts
bmj.com, 20 Apr 2007 [Full text]

Ethics and Disease Prevention

Bob Parke
bmj.com, 23 Apr 2007 [Full text]

Public health implications of reducing sodium

Kenneth A Hoekstra
bmj.com, 24 Apr 2007 [Full text]

Re: Sodium reduction, cardiovascular outcome and smoking

Nancy R. Cook
bmj.com, 24 Apr 2007 [Full text]

The variability factors in the study of dietary sodium restriction on cardiovascular outcomes

Munir E Nassar
bmj.com, 28 Apr 2007 [Full text]

Salt sensitivity?

Joan McClusky
bmj.com, 28 Apr 2007 [Full text]

“Sodium Reduction” seems an enticing label, but what is the full recipe?

Paul P Glasziou
bmj.com, 29 Apr 2007 [Full text]

Health - the product of environment, culture and institutions

M Justin S Zaman, et al.
bmj.com, 30 Apr 2007 [Full text]

BHF puts salt firmly on heart menu

Qaim Zaidi
bmj.com, 1 May 2007 [Full text]

Lowering Salt: Time for Action

Michael Jacobson
bmj.com, 1 May 2007 [Full text]

Overall benefit is what matters: disease specific outcomes are only explanatory variables

C Kevin Connolly
bmj.com, 2 May 2007 [Full text]

Hypertension and Moderate Restriction of Salt intake in Food is Beneficial as Preventive measure for Normotensives aswell as Hypertensives in West Bengal State of India

Professor Pranab Kumar Bhattacharya, et al.
bmj.com, 3 May 2007 [Full text]

Salt restriction may jeopardize the elimination of Iodine Deficiency Disorder

Kishan Kumar Jani, et al.
bmj.com, 3 May 2007 [Full text]

Salt intake should be minimum but this minimum may differ in hot and cold countries

Neeru Gupta, et al.
bmj.com, 3 May 2007 [Full text]

Salt intake, temperature and iodization

Francesco P Cappuccio
bmj.com, 4 May 2007 [Full text]

Fluid replacement without electrolytes in hot weather can cause hyponatremia

Kishan Kumar Jani, et al.
bmj.com, 5 May 2007 [Full text]

I met a Milly Mole

Alexander Jablanczy
bmj.com, 25 May 2007 [Full text]

Soluble Sea Salt is better

GEORGE Y CALDWELL, et al.
bmj.com, 28 May 2007 [Full text]